Kazam Joshua A 4
4 · Allogene Therapeutics, Inc. · Filed Mar 9, 2022
Insider Transaction Report
Form 4
Kazam Joshua A
Director
Transactions
- Other
Common Stock
2022-03-07+412,618→ 671,503 total - Gift
Common Stock
2022-03-07−412,618→ 258,885 total
Footnotes (1)
- [F1]The transactions reported in this form did not involve a purchase or sale of securities by the reporting person. On March 7, 2022, the reporting person acquired securities previously held in trust for the benefit of the reporting person arising from the termination of the trust. On the same day, the reporting person transferred the same securities to an irrevocable grantor trust having an independent trustee. The reporting person disclaims beneficial ownership of these shares except to the extent, if any, of the reporting person's pecuniary interest therein.